| Disease ID | Disease name | Reference |
|---|
| MESH:D000068079 |
Motor Disorders |
PMID:26859824 |
| MESH:D000072660 |
Teratozoospermia |
PMID:36807407; PMID:37471654 |
| MESH:D001008 |
Anxiety Disorders |
PMID:35527006; PMID:37385299 |
| MESH:D001259 |
Ataxia |
PMID:20680508 |
| MESH:D001327 |
Autoimmune Diseases |
PMID:12825236 |
| MESH:D001847 |
Bone Diseases |
PMID:24959776 |
| MESH:D001851 |
Bone Diseases, Metabolic |
PMID:23376407 |
| MESH:D001927 |
Brain Diseases |
PMID:17882470 |
| MESH:D001929 |
Brain Edema |
PMID:21215787; PMID:30703413 |
| MESH:D001930 |
Brain Injuries |
PMID:15014207; PMID:24148954; PMID:30445054; PMID:30703413 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
PMID:23396744; PMID:24782466 |
| MESH:D003072 |
Cognition Disorders |
PMID:20381573; PMID:20829427; PMID:21126476; PMID:35527006 |
| MESH:D003866 |
Depressive Disorder |
PMID:37385299 |
| MESH:D004480 |
Ectromelia |
PMID:11402670 |
| MESH:D004487 |
Edema |
PMID:25031709 |
| MESH:D004677 |
Encephalocele |
PMID:11402670 |
| MESH:D005313 |
Fetal Death |
PMID:11402670 |
| MESH:D005317 |
Fetal Growth Retardation |
PMID:19769572; PMID:32073883 |
| MESH:D005327 |
Fetal Resorption |
PMID:11402670 |
| MESH:D006311 |
Hearing Disorders |
PMID:12062763 |
| MESH:D006402 |
Hematologic Diseases |
PMID:25800560 |
| MESH:D006461 |
Hemolysis |
PMID:19428946 |
| MESH:D006948 |
Hyperkinesis |
PMID:20829427; PMID:25845299 |
| MESH:D006968 |
Hypersensitivity, Delayed |
PMID:17657459 |
| MESH:D006973 |
Hypertension |
PMID:11454931; PMID:11729227; PMID:14520025 |
| MESH:D007154 |
Immune System Diseases |
PMID:25800560 |
| MESH:D007248 |
Infertility, Male |
PMID:30510688; PMID:36088639 |
| MESH:D007249 |
Inflammation |
PMID:23030477 |
| MESH:D007674 |
Kidney Diseases |
PMID:17882470; PMID:22581110; PMID:22728154; PMID:23428833; PMID:26078282; PMID:30980911; PMID:32116774 |
| MESH:D007859 |
Learning Disabilities |
PMID:20138853; PMID:20381573; PMID:22362014; PMID:22811615; PMID:23134599; PMID:23867794; PMID:24148954; PMID:24200854; PMID:25242007; PMID:29447957; PMID:29505838; PMID:30742882 |
| MESH:D008171 |
Lung Diseases |
PMID:22581110 |
| MESH:D008569 |
Memory Disorders |
PMID:20138853; PMID:20381573; PMID:22362014; PMID:22811615; PMID:23867794; PMID:24148954; PMID:24200854; PMID:25242007; PMID:26797587; PMID:29203278; PMID:29447957; PMID:29505838; PMID:30742882 |
| MESH:D009069 |
Movement Disorders |
PMID:17404837; PMID:21868162 |
| MESH:D009202 |
Cardiomyopathies |
PMID:21378372 |
| MESH:D009293 |
Opioid-Related Disorders |
PMID:26478469 |
| MESH:D009336 |
Necrosis |
PMID:19347332; PMID:22728154 |
| MESH:D009358 |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
PMID:32073883 |
| MESH:D009401 |
Nephrosis |
PMID:12237977; PMID:12425114 |
| MESH:D009410 |
Nerve Degeneration |
PMID:17959157; PMID:30445054; PMID:30703413; PMID:32208856 |
| MESH:D009845 |
Oligospermia |
PMID:24140753; PMID:36807407; PMID:37471654 |
| MESH:D009901 |
Optic Nerve Diseases |
PMID:23680456 |
| MESH:D010243 |
Paralysis |
PMID:11402670 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
PMID:17404837; PMID:21126476; PMID:2143947; PMID:22279679; PMID:22362014; PMID:22609695; PMID:22613225; PMID:23086308; PMID:23146751; PMID:24200854; PMID:24260418; PMID:26478469; PMID:27492863; PMID:27984133; PMID:32073883; PMID:35527006 |
| MESH:D011596 |
Psychomotor Disorders |
PMID:25088297 |
| MESH:D012164 |
Retinal Diseases |
PMID:23680456 |
| MESH:D012640 |
Seizures |
PMID:8326083 |
| MESH:D013163 |
Splenomegaly |
PMID:17657459 |
| MESH:D013733 |
Testicular Diseases |
PMID:25981801; PMID:34051273; PMID:36088639; PMID:36807407; PMID:37471654 |
| MESH:D013959 |
Thyroid Diseases |
PMID:34553816 |
| MESH:D015430 |
Weight Gain |
PMID:29203278 |
| MESH:D015431 |
Weight Loss |
PMID:11402670; PMID:12237977; PMID:12425114; PMID:15014207; PMID:17882470; PMID:20600549; PMID:20680508; PMID:25975991; PMID:30980912; PMID:33862172 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
PMID:23760256 |
| MESH:D019465 |
Craniofacial Abnormalities |
PMID:19769572 |
| MESH:D019973 |
Alcohol-Related Disorders |
PMID:30385389 |
| MESH:D020258 |
Neurotoxicity Syndromes |
PMID:25496357; PMID:32208856 |
| MESH:D020263 |
Lead Poisoning, Nervous System |
PMID:17047031; PMID:21126476; PMID:21868162; PMID:23855546 |
| MESH:D020264 |
Lead Poisoning, Nervous System, Childhood |
PMID:23086308 |
| MESH:D020265 |
Lead Poisoning, Nervous System, Adult |
PMID:23867794 |
| MESH:D052456 |
Hypoalphalipoproteinemias |
PMID:23760256 |
| MESH:D056486 |
Chemical and Drug Induced Liver Injury |
PMID:16581537; PMID:17882470; PMID:20930461; PMID:28817314; PMID:30251767; PMID:30623991 |
| MESH:D056784 |
Leukoencephalopathies |
PMID:23680456 |
| MESH:D058225 |
Plaque, Amyloid |
PMID:29908845 |
| MESH:D064420 |
Drug-Related Side Effects and Adverse Reactions |
PMID:22728154 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.